BioCentury
ARTICLE | Company News

Management tracks

March 17, 2015 12:53 AM UTC

Oral therapies developer Chiasma Inc. (Jerusalem, Israel) named Mark Leuchtenberger president and CEO. Leuchtenberger was president and CEO of Acusphere Inc. (Pink:ACUS). Leuchtenberger succeeds Roni Mamluk, whom Chiasma named chief development officer.

mRNA technology company Moderna Therapeutics Inc. (Cambridge, Mass.) named Tal Zaks CMO. Zaks was SVP and head of global oncology at Sanofi (Euronext:SAN; NYSE:SNY). ...